SCHEMBL769274

SCHEMBL769274

C=COC12CC3CC(C1)CC(OC=C)(C3)C2

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.31
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4805893 0.86 TSHR (0.34) NPSR1
SCHEMBL5195240 0.86 PKM (0.42)
SCHEMBL4804837 0.86
SCHEMBL4809569 0.86 PKM (0.42) ALDH1A1
SCHEMBL414172 0.85 NPSR1 (0.38) NPSR1
SCHEMBL1061868 0.85
SCHEMBL12869523 0.80 MEN1 (0.33) MEN1ALDH1A1KMT2A
SCHEMBL5192002 0.80 PKM (0.43) NPSR1MEN1ALDH1A1KMT2A
SCHEMBL5195627 0.78 NPC1 (0.30)
SCHEMBL5194837 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024191208-A1 COMPOSITION FOR ENCAPSULATING ORGANIC LIGHT-EMITTING DIODES AND ORGANIC LIGHT-EMITTING DIODES DISPLAY COMPRISING ORGANIC LAYER PREPARED USING SAME 삼성에스디아이주식회사 2024-09-19 WO claimed
EP-1967540-B1 CURABLE COMPOSITION KANEKA CORP (JP) 2013-04-03 EP claimed
US-8263725-B2 Curable composition KANEKA CORPORATION (JP) 2012-09-11 US claimed
US-20100222525-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2010-09-02 US claimed
EP-1967540-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2008-09-10 EP claimed
US-20260020362-A1 RIBBED SUBSTRATE AND OPTICAL SEMICONDUCTOR DEVICE KANEKA CORP (JP) 2026-01-15 US disclosed
US-20250066595-A1 CURABLE RESIN COMPOSITION THREEBOND CO., LTD. (JP) 2025-02-27 US disclosed
US-20250015105-A1 SUBSTRATE LAMINATE, IMAGE SENSOR, AND METHOD FOR MANUFACTURING SUSTRATE LAMINATE KANEKA CORPORATION (JP) 2025-01-09 US disclosed
EP-4455225-A1 CURABLE RESIN COMPOSITION ThreeBond Co., Ltd. (JP) 2024-10-30 EP disclosed
WO-2024191208-A1 COMPOSITION FOR ENCAPSULATING ORGANIC LIGHT-EMITTING DIODES AND ORGANIC LIGHT-EMITTING DIODES DISPLAY COMPRISING ORGANIC LAYER PREPARED USING SAME 삼성에스디아이주식회사 2024-09-19 WO disclosed
CN-118434809-A Curable resin composition 三键有限公司 2024-08-02 CN disclosed
US-20240206322-A1 OPTICAL SEMICONDUCTOR DEVICE, METHOD FOR MANUFACTURING SAME, SOLID-STATE IMAGING DEVICE, AND ELECTRONIC DEVICE KANEKA CORPORATION (JP) 2024-06-20 US disclosed
US-7271297-B2 Process for producing vinyl ether compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2007-09-18 US disclosed
EP-1826196-A2 Vinyl ether compounds Daicel Chemical Industries, Ltd. (JP) 2007-08-29 EP disclosed
US-20060205957-A1 Process for producing vinyl ether compounds ISHII YASUTAKA 2006-09-14 US disclosed
US-7074970-B2 Process for producing vinyl ether compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2006-07-11 US disclosed
US-20050004391-A1 Adamantyl vinyl ether compound and production process for the same IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2005-01-06 US disclosed
EP-1486480-A1 Adamantyl vinyl ether compound and production process for the same Idemitsu Petrochemical Co., Ltd. (JP) 2004-12-15 EP disclosed
US-20030083529-A1 Process for producing vinyl ether compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-05-01 US disclosed
EP-1288186-A2 Vinyl ether compounds and preparation process thereof Daicel Chemical Industries, Ltd. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260020362-A1 RIBBED SUBSTRATE AND OPTICAL SEMICONDUCTOR DEVICE SOST, CASK, STRADA NPSR1 4455/4885MEN1 4264/4885ALDH1A1 477/4885
US-20050004391-A1 Adamantyl vinyl ether compound and production process for the same NOTUM, CYP4A11, CYP4F11 NPSR1 4543/4885MEN1 1442/4885ALDH1A1 414/4885
US-20060205957-A1 Process for producing vinyl ether compounds ETV6, CYP3A4, SUV39H2 NPSR1 4182/4885MEN1 1435/4885ALDH1A1 1064/4885
US-20030083529-A1 Process for producing vinyl ether compounds SRD5A2, RPS4X, RUVBL2 NPSR1 4677/4885MEN1 2290/4885ALDH1A1 673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.